Qualitative [18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability

European Journal of Nuclear Medicine

Volumn 23, Issue 6, 1996, Pages 618-623

  Scheidhauer, Klemens ^a,c   Scharl, Anton ^a   Pietrzyk, Uwe ^b   Wagner, Rainer ^b   Göhring, Uwe J ^a   Schomäcker, Klaus ^a   Schicha, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Positron emission tomography; Primary breast cancer; Staging

Indexed keywords

DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; TIME; ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; ULTRASONOGRAPHY, MAMMARY;

EID: 0029665874     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00834522     Document Type: Article

References (19)

1. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
2. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-664.
3. Pietrzyk U, Scheidhauer K, Scharl A, Schuster A, Schicha H. Presurgial visualization of primary breast carcinoma with PET emission and transmission imaging. J Nucl Med 1995; 36: 1882-1884.
4. Adler LP, Crowe JP, al Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with (F-18)-2-deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187: 743-750.
5. Glaspy JA, Hawkins R, Hoh CK, Phelps ME. Use of positron emission tomography in oncology. Oncology-Huntigt 1993; 7: 41-52.
6. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the position scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16: 804-813.
7. 18F)-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
8. Pietrzyk U, Herholz K, Heiss WD. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 1990; 14: 51-59.
9. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky J, Würker M, Heiss WD. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI, and CT brain studies. J Nucl Med 1994; 35: 2011-2018.
10. Wahl RL, Cody RL, Hutchins GD, Mugett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1991; 179: 765-770.
11. Lichter AS, Adler DD, August DA, Honig SF, Lippmann ME, Schottenfeld DA. Breast Cancer. In: Hoskins JW, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology. Philadelphia: Lippincott; 1992: 827-891.
12. 18F)-fluorodeoxyglucose uptake in tumours: kinetic vs. steady-state methods with reference to plasma insulin. J Comput Assist Tomogr 1993; 17: 115-123.
13. Wahl R, Henry C, Ethier S. Serum glucose: effects on tumour and normal tissue accumulation of 2-(F-18)-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647.
14. D'Orsi C. To follow or not to follow, that is the question. Radiology 1992; 184: 306.
15. Kopans D. The accuracy of mammographic interpretation. N Engl J Med 1994; 331: 1521-1522.
16. Elmore J, Wells C, Lee C, Howard D, Feinstein A. Variability in radiologists' interpretation of mammograms. N Engl J Med 1994; 331: 1493-1499.
17. Kopans D. Breast imaging and the standard of care for the symptomatic patient. Radiology 1993; 187: 608-611.
18. Varas X, Leborgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology 1991; 179: 463-468.
19. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1992; 184: 409-414.